| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief People Officer
1 company
Lewis Karen is a Chief People Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief People Officer | Sale+OE | 5,000 | $75.00 | $375,000.00 | -10.8% | +16.4% | -27.4% | |
| Feb 23, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief People Officer | Sell | 1,104 | $68.76 | $75,911.04 | -2.6% | +29.3% | +2.3% | |
| Jan 30, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief People Officer | Sell | 883 | $52.76 | $46,587.08 | -2.4% | +57.2% | +25.1% | |
| Jan 23, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief People Officer | Sell | 2,955 | $51.58 | $152,418.90 | -7.3% | +75.4% | +30.8% |